Idifarma provides contract development and manufacturing services for niche and highly potent generic or innovative drugs

Pharmaceutical R&D and Manufacturing Services

Idifarma is an independent, privately-owned pharmaceutical CDMO based in Spain and specializing in highly potent drugs.

With an experienced staff of 130+ people and over 100 international clients, Idifarma provides a full range of services covering most of the lifecycle of any pharmaceutical product from first pre-formulation trials to commercial manufacturing: drug formulation, development and validation of analytical methods, quality control and batch release in the EU, stability studies, regulatory affairs, GMP contract manufacturing and packaging for clinical or commercial use.

Its state-of-the-art facility features a purpose-built high containment plant for GMP manufacturing of oral solid dosage forms, for both highly potent and non-potent drugs.

Idifarma’s expertise, capabilities and proven track record make it the perfect partner for the development of your projects.


Covid-19 Announcement

IDIFARMA is fully committed to the well-being of our employees, the quality of the services we provide to our valuable clients and our contribution to the general health of all people.


Idifarma will attend the following events during 2020 Would you like to meet us? Contact us at to schedule a meeting!


Idifarma will participate in the event "Covid-19 virtual Partnering" (4-6th May), a great opportunity to meet and match skills and efforts to develop and produce treatments and solutions to tackle the COVID-19 pandemic.

#PartenringAgainstCovid19 #COVID19

Our colleagues from @Idifarma are collaborating in this interesting project led by @nucaps_nano

We have presented our project 'Nanocapsules against COVID-19' to the Carlos III Health Institute. With @unav and @Idifarma as partners, we have developed a product than encapsulates #resveratrol with #zein and improves the effects of #covid19.


Hemos presentado nuestro proyecto 'Nanocápsulas contra el COVID-19' al Institutode Salud Carlos III. Con @unav e @Idifarma como partners, hemos desarrollado un producto que encapsula #resveratrol con #zeína y mejora los efectos causados por el #covid19.


In order to ensure the business continuity of the company activities in this challenging health crisis, Idifarma have implemented important safety measures.

You can find them in the following link

We are all in this together, and together we will prevail

Load More...

Do you want to receive the latest news from Idifarma?

Utilizamos cookies propias y de terceros para realizar el análisis de la navegación de los usuarios y mejorar nuestros servicios. Si continúa navegando, consideramos que acepta su uso. Puede obtener más información, o bien conocer cómo cambiar la configuración pulse aquí ACEPTAR

Aviso de cookies